rheomacrodex in sodium chloride
pfizer new zealand limited - dextran 40 10%; sodium chloride 0.9% - solution for infusion - 10%/0.9% - active: dextran 40 10% sodium chloride 0.9%
dextran 40
baxter healthcare limited - dextran 40 glucose - solution for infusion - 10/5 %w/v %w/v
10% dextran 40 in 0.9% sodium chloride 500ml injection bag fkb5043g
baxter healthcare pty ltd - dextran 40, quantity: 100 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)
10% dextran 40 in 5% glucose 500ml injection fkb5053g
baxter healthcare pty ltd - dextran 40, quantity: 100 g/l; glucose monohydrate, quantity: 50 g/l - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)
dextran '40' 10% in glucose 5% solution for injection 500ml bags
baxter healthcare ltd - dextran 40; glucose anhydrous - infusion - 100mg/1ml ; 50mg/1ml
dextran '40' 10% in sodium chloride 0.9% solution for injection 500ml bags
baxter healthcare ltd - dextran 40 - infusion - 100mg/1ml
10% dextran 40 iv infusion in 0.9%w/v sodium chloride iv infusion injection infusion
bahrain pharmacy - dextran 40 - injection infusion
warfarin sodium tablet
golden state medical supply, inc. - warfarin sodium (unii: 6153cwm0cl) (warfarin - unii:5q7zvv76ei) - warfarin sodium 1 mg
lisinopril tablet
international laboratories, llc - lisinopril (unii: e7199s1ywr) (lisinopril anhydrous - unii:7q3p4bs2fd) - lisinopril 2.5 mg - lisinopril tablet usp is indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variet
benazepril hydrochloride tablet film coated
international laboratories, llc - benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703) - benazepril hydrochloride 40 mg